Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

How soon will digital endpoints become a cornerstone for future drug development?
Philip Boehme, Arne Hansen, Ronenn Roubenoff, et al.
Drug Discovery Today (2018) Vol. 24, Iss. 1, pp. 16-19
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

A Roadmap to Inform Development, Validation and Approval of Digital Mobility Outcomes: The Mobilise-D Approach
Lynn Rochester, Claudia Mazzà, Arne Mueller, et al.
Digital Biomarkers (2020) Vol. 4, Iss. Suppl. 1, pp. 13-27
Open Access | Times Cited: 103
Systematic Review Looking at the Use of Technology to Measure Free-Living Symptom and Activity Outcomes in Parkinson’s Disease in the Home or a Home-like Environment
Catherine Morgan, Michal Rolinski, Róisín McNaney, et al.
Journal of Parkinson s Disease (2020) Vol. 10, Iss. 2, pp. 429-454
Open Access | Times Cited: 87
Artificial intelligence-enhanced drug design and development: Toward a computational precision medicine
Philippe Moingeon, Mélaine A. Kuenemann, Mickaël Guedj
Drug Discovery Today (2021) Vol. 27, Iss. 1, pp. 215-222
Closed Access | Times Cited: 70
Opportunities and Challenges for Decentralized Clinical Trials: European Regulators’ Perspective
Amos J. de Jong, Tessa I. van Rijssel, Mira G. P. Zuidgeest, et al.
Clinical Pharmacology & Therapeutics (2022) Vol. 112, Iss. 2, pp. 344-352
Open Access | Times Cited: 54
Virtual patients, digital twins and causal disease models: Paving the ground for in silico clinical trials
Philippe Moingeon, Marylore Chenel, Cécile F. Rousseau, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 7, pp. 103605-103605
Closed Access | Times Cited: 39
Artificial intelligence-driven drug development against autoimmune diseases
Philippe Moingeon
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 7, pp. 411-424
Open Access | Times Cited: 24
Clinical translation of nanomedicine with integrated digital medicine and machine learning interventions
Farooq Ahmad, Tahir Muhmood
Colloids and Surfaces B Biointerfaces (2024) Vol. 241, pp. 114041-114041
Closed Access | Times Cited: 8
Toward a Regulatory Qualification of Real-World Mobility Performance Biomarkers in Parkinson’s Patients Using Digital Mobility Outcomes
Marco Viceconti, Sabina Hernandez Penna, Wilhelmus Dartee, et al.
Sensors (2020) Vol. 20, Iss. 20, pp. 5920-5920
Open Access | Times Cited: 52
Precompetitive Consensus Building to Facilitate the Use of Digital Health Technologies to Support Parkinson Disease Drug Development through Regulatory Science
Diane Stephenson, Robert Alexander, Varun Aggarwal, et al.
Digital Biomarkers (2020) Vol. 4, Iss. Suppl. 1, pp. 28-49
Open Access | Times Cited: 52
Consensus based framework for digital mobility monitoring
Felix Kluge, Silvia Del Din, Andrea Cereatti, et al.
PLoS ONE (2021) Vol. 16, Iss. 8, pp. e0256541-e0256541
Open Access | Times Cited: 42
German Version of SARC-F: Translation, Adaption, and Validation
Michael Drey, Uta Ferrari, Marina Schraml, et al.
Journal of the American Medical Directors Association (2020) Vol. 21, Iss. 6, pp. 747-751.e1
Closed Access | Times Cited: 49
Development of Novel, Value-Based, Digital Endpoints for Clinical Trials: A Structured Approach Toward Fit-for-Purpose Validation
Matthijs D. Kruizinga, Frederik E. Stuurman, Vasileios Exadaktylos, et al.
Pharmacological Reviews (2020) Vol. 72, Iss. 4, pp. 899-909
Open Access | Times Cited: 41
Digital Endpoints: Definition, Benefits, and Current Barriers in Accelerating Development and Adoption
Matthew Landers, Ray Dorsey, Suchi Saria
Digital Biomarkers (2021) Vol. 5, Iss. 3, pp. 216-223
Open Access | Times Cited: 38
Walking-related digital mobility outcomes as clinical trial endpoint measures: protocol for a scoping review
Ashley Polhemus, Ronny Bergquist, Magda Bosch de Basea, et al.
BMJ Open (2020) Vol. 10, Iss. 7, pp. e038704-e038704
Open Access | Times Cited: 38
How to Design AI-Driven Clinical Trials in Nuclear Medicine
Gaspar Delso, Davide Cirillo, Joshua Kaggie, et al.
Seminars in Nuclear Medicine (2020) Vol. 51, Iss. 2, pp. 112-119
Closed Access | Times Cited: 25
A New Digital Value Chain Model with PLC in Biopharmaceutical Industry: The Implication for Open Innovation
YongChan Kim, Erdal Atukeren, Yeon-Woo Lee
Journal of Open Innovation Technology Market and Complexity (2022) Vol. 8, Iss. 2, pp. 63-63
Open Access | Times Cited: 14
BioMeT and Algorithm Challenges: A Proposed Digital Standardized Evaluation Framework
Alan Godfrey, Jennifer C. Goldsack, Pamela Tenaerts, et al.
IEEE Journal of Translational Engineering in Health and Medicine (2020) Vol. 8, pp. 1-8
Open Access | Times Cited: 20
“It’s Not as Simple as Just Looking at One Chart”: A Qualitative Study Exploring Clinician’s Opinions on Various Visualisation Strategies to Represent Longitudinal Actigraphy Data
Alison Keogh, William Johnston, Mitchell Ashton, et al.
Digital Biomarkers (2020) Vol. 4, Iss. Suppl. 1, pp. 87-99
Open Access | Times Cited: 8
Digital biomarkers for post-licensure safety monitoring
Luis Garcia‐Gancedo, Andrew Bate
Drug Discovery Today (2022) Vol. 27, Iss. 11, pp. 103354-103354
Open Access | Times Cited: 5
Multidimensional Biomechanics-Based Score to Assess Disease Progression in Duchenne Muscular Dystrophy
Carolina Migliorelli, Meritxell Gómez-Martínez, Paula Subías-Beltrán, et al.
Sensors (2023) Vol. 23, Iss. 2, pp. 831-831
Open Access | Times Cited: 2
Digital Double Diamond (DiDD) Model Analysis of National Competitiveness Under Digital Transformation: An Application to Healthcare and Pharmaceutical Industries in South Korea and Switzerland
YongChan Kim, Erdal Atukeren, Yeon W. Lee
International Journal of Global Business and Competitiveness (2023) Vol. 18, Iss. S1, pp. 1-18
Open Access | Times Cited: 2
The long-term clinical impact of digital endpoints and biomarkers in data collection
Ahmad Z. Al Meslamani
Expert Review of Pharmacoeconomics & Outcomes Research (2024) Vol. 24, Iss. 6, pp. 697-699
Open Access
The utility and impact of digital endpoints for improving breast cancer outcomes
Ismail Jatoi, Jonathan Gelfond
Expert Review of Pharmacoeconomics & Outcomes Research (2024), pp. 1-5
Closed Access
P.O.L.A.R. Star: A New Framework Developed and Applied by One Mid-Sized Pharmaceutical Company to Drive Digital Transformation in R&D
Riccardo Mariani, Maria Carmela De Vuono, Elena Businaro, et al.
Pharmaceutical Medicine (2024) Vol. 38, Iss. 5, pp. 343-353
Open Access
Consensus based framework for digital mobility monitoring
Felix Kluge, Silvia Del Din, Andrea Cereatti, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top